Suppr超能文献

组织型纤溶酶原激活物抗原及活性在弥散性血管内凝血中的表达及其与临床病理的相关性

Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.

作者信息

Francis R B, Seyfert U

机构信息

Department of Medicine, Los Angeles County-University of Southern California Medical Center.

出版信息

J Lab Clin Med. 1987 Nov;110(5):541-7.

PMID:3117952
Abstract

The fibrinolytic response to disseminated intravascular coagulation (DIC) has been considered important both in preventing thrombosis and in contributing to hemorrhage. Detailed studies of fibrinolysis in DIC are lacking, however. We measured tissue plasminogen activator (t-PA) antigen and activity levels in 74 patients with DIC, 53 hospitalized patients with similar illnesses without DIC, and 36 healthy normal subjects, using sensitive, specific assays. Mean t-PA antigen levels were significantly higher in patients with DIC than in either hospitalized control subjects or normal individuals in most disease categories studied. Highest t-PA antigen levels were seen in patients with liver disease, but patients with DIC without liver disease also had significantly elevated t-PA antigen. Detectable free t-PA activity was infrequently seen in patients with DIC, however. No correlation was found with either thrombotic or hemorrhagic complications and levels of t-PA antigen or activity in DIC, with the possible exception of increased t-PA activity in two patients with intracranial hemorrhage. Bleeding complications were seen almost exclusively in patients with underlying anatomic lesions, and thrombotic complications were usually associated with other known predisposing factors. We conclude that t-PA antigen is usually elevated in DIC, but free t-PA activity is infrequently seen, most likely because of increased levels of t-PA inhibitor. The presence or absence of free t-PA activity does not appear to predict which patients with DIC will develop hemorrhage or thrombosis.

摘要

对弥散性血管内凝血(DIC)的纤溶反应在预防血栓形成和导致出血方面都被认为很重要。然而,目前缺乏对DIC纤溶的详细研究。我们使用灵敏、特异的检测方法,测量了74例DIC患者、53例患有类似疾病但无DIC的住院患者以及36例健康正常受试者的组织型纤溶酶原激活物(t-PA)抗原和活性水平。在大多数所研究的疾病类别中,DIC患者的平均t-PA抗原水平显著高于住院对照受试者或正常个体。t-PA抗原水平最高的是肝病患者,但无肝病的DIC患者t-PA抗原也显著升高。然而,DIC患者中很少能检测到游离t-PA活性。在DIC中,未发现血栓形成或出血并发症与t-PA抗原或活性水平之间存在相关性,颅内出血的两名患者的t-PA活性增加可能是个例外。出血并发症几乎仅见于有潜在解剖学病变的患者,血栓形成并发症通常与其他已知的易感因素有关。我们得出结论,DIC患者的t-PA抗原通常升高,但很少能见到游离t-PA活性,这很可能是因为t-PA抑制剂水平升高。游离t-PA活性的有无似乎并不能预测哪些DIC患者会发生出血或血栓形成。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验